Order Article Reprints

Lilieholm C, Zaborek J, Kwon O, Adeniyi AO, Kerr CP, Comas Rojas H, Bio Idrissou M, Ferreira CA, Clark PA, Jin WJ, et al. Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors. Radiation. 2025; 5(4):39. https://doi.org/10.3390/radiation5040039

Lilieholm, Cynthia, Jen Zaborek, Ohyun Kwon, Adedamola O. Adeniyi, Caroline P. Kerr, Hansel Comas Rojas, Malick Bio Idrissou, Carolina A. Ferreira, Paul A. Clark, Won Jong Jin, and et al. 2025. "Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors" Radiation 5, no. 4: 39. https://doi.org/10.3390/radiation5040039

Lilieholm, C., Zaborek, J., Kwon, O., Adeniyi, A. O., Kerr, C. P., Comas Rojas, H., Bio Idrissou, M., Ferreira, C. A., Clark, P. A., Jin, W. J., Grudzinski, J. J., Erbe, A. K., Aluicio-Sarduy, E., Kanagasundaram, T., Wilson, J. J., Engle, J. W., Hernandez, R., Bednarz, B., Morris, Z. S., & Weichert, J. P. (2025). Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors. Radiation, 5(4), 39. https://doi.org/10.3390/radiation5040039